Deciphera Pharmaceuticals’ Post

We are excited about the recent European Commission approval of our new medicine for people living with tenosynovial giant cell tumor (#TGCT)! Learn more: https://lnkd.in/ed5zs6sQ #CancerResearch

  • No alternative text description for this image
John Davidson

Business Development Director @ Numerus Ltd

3w

Congratulations Deciphera team!

Like
Reply
Peter Mozerov

Pharmaceutical l Life Sciences l Commercial Strategy l Launch in Europe l Licensing l Partnering l M&A

3w

Bravo Deciphera team!

Like
Reply
Mantasha Choudhary

B2B SaaS Marketer | Driving Growth for Pharma SaaS & Clinical Trial Tech (CTMS, eTMF, RWE) | Compliance-Driven Marketing | ABM • Content Strategy • Demand Generation • Pipeline Growth | GTM | Scientific Storytelling

3w

congratulations 🙌

Like
Reply
John Luddy

Senior Manager, Clinical Science at ONO Pharma USA, Inc.

2w

Great Work! 😊 💪 👏

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories